Related Experiment Video
Updated: Jul 16, 2026
17:13
Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
Published on: April 28, 2013
[Anemia after renal transplantation]
1Struttura Operativa Complessa di Nefrologia, Dialisi e Trapianto Renale, Azienda Ospedaliero-Universitaria, S. Maria della Misericordia, Udine - Italy. montanaro.domenico@aoud.sanita.fvg.it
Summary
Post-transplant anemia (PTA) affects many kidney transplant recipients, often persisting despite successful transplantation. Further research is needed to optimize treatment for this common complication.
Area of Science:
- Nephrology
- Transplantation Medicine
- Hematology
Context:
- Anemia is common in end-stage kidney disease and often resolves post-transplantation.
- However, a significant portion of kidney transplant recipients develop or continue to experience anemia.
- Post-transplant anemia (PTA) is less understood than anemia in end-stage renal disease.
Purpose:
- To review the current understanding of post-transplant anemia (PTA) in kidney transplant recipients.
- To highlight the prevalence, risk factors, and potential consequences of PTA.
- To discuss current treatment strategies and the need for further research.
Summary:
- PTA affects 30-40% of kidney transplant patients within 5 years, with prevalence increasing over time.
- Risk factors include decreased renal allograft function, iron deficiency, infections, and drug toxicities.
- PTA is linked to increased cardiovascular disease risk, yet treatments like iron and erythropoietin are underused.
Impact:
- Identifies PTA as a significant complication in kidney transplant recipients.
- Underscores the underutilization of effective therapies like erythropoietin.
- Calls for prospective studies to establish optimal hemoglobin targets and therapeutic benefits of erythropoietin for cardiovascular and renal protection.
More Related Videos
Related Concept Videos
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...